For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Smoking cessation - Independent medicine & health information for consumers & professionals Information on smoking cessation
Show health professional infoLatest independent information about smoking cessation, including medicine and non-drug treatments, written and reviewed by experts in Australia.
Smoking cessation is also known as quitting smoking.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
| Quit smoking - Independent medicine & health information | The combination of smoking & diabetes increases the risk of heart disease & other complications. Quitting smoking will improve your health & reduce the risk of other illnesses. |
Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
| Managing lipids -Reducing CVD risk | Outlines tools for identifying people at increased cardiovascular risk and strategies to help people stay on effective treatment. Many could benefit from a lipid-modifying drug but are not being treated. |
Professional publication - NPS News | Health Professionals | 2011-02-01 00:00:00 |
| Nicotine patches (Nicabate P, Nicorette, Nicotinell Step 1) for smoking cessation | nicotine nicorette transdermal patches 15mg/16 hour; nicotine nicotinell step 1 transdermal patches 21mg/24 hour; nicotine nicabate p transdermal patches 21mg/24 hour |
Professional publication - NPS RADAR - Review | Health Professionals | 2011-02-01 00:00:00 |
| Varenicline (Champix) for smoking cessation | Review of varenicline (Champix) for smoking cessation, including adverse effects, treatment efficacy, and drug interactions. |
Professional publication - NPS RADAR - Review | Health Professionals | 2011-08-01 00:00:00 |
| Quit smoking - Independent medicine & health information | The combination of smoking & diabetes increases the risk of heart disease & other complications. Quitting smoking will improve your health & reduce the risk of other illnesses. |
Web page | Consumers,Others,Research & Evaluation community | 2011-12-06 00:00:00 |
| Varenicline (Champix) safety update: possible increase in serious cardiovascular events | Varenicline (Champix) — possible increase in serious cardiovascular events. |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2011-08-01 00:00:00 |
| Clinical audit: Management of stable COPD and smoking cessation | How are you managing your patients with stable chronic obstructive pulmonary disease who are current smokers? Review 10 patients |
Professional activity - Clinical audit | Health Professionals | 2010-05-01 00:00:00 |
| Clinical e-Audit: Lipids | Clinical e-audit to help GPs review their management of patients who are at risk of CVD and may benefit from lipid-modifying therapy |
Professional activity - Clinical audit | Health Professionals | 2010-07-01 00:00:00 |
| Smoking cessation patient data collection form | Smoking cessation patient data collection form to be completed after serving customers who request nicotine replacement therapy (NRT). |
Professional activity - Pharmacy Practice Review | Health Professionals | 2008-04-26 00:00:00 |
| Reducing CVD risk: lifestyle, statins and ezetimibe | This pharmacy practice review provides pharmacists with the opportunity to review the optimal use of lipid-modifying medicines in patients at risk of cardiovascular disease |
Professional activity - Pharmacy Practice Review | Health Professionals | 2010-06-10 00:00:00 |
| Case study 63: Managing chronic obstructive pulmonary disease | Damien, a 58-year-old brick layer comes for a review of the management of his chronic obstructive pulmonary disease (COPD) as his symptoms have become more troublesome over the past month. |
Professional activity - Case study | Health Professionals | 2010-04-01 00:00:00 |
| Case study 42 report: Managing COPD exacerbations | Middle-aged man with COPD presents with worsening dyspnoea, cough and increasing purulent sputum production over the past 3 days. |
Professional activity - Case study report | Health Professionals | 2006-06-01 00:00:00 |
| Case study 67: CVD risk: guiding lipid management | Ric is a 49-year-old IT consultant who has come to see you concerned that he is at risk of a heart attack |
Professional publication - NPS News | Health Professionals | 2011-02-01 00:00:00 |
| Quit smoking | Outlines quit smoking strategies and role of nicotine replacement and Champix. Discusses COPD (chronic obstructive pulmonary disease) and its diagnosis. |
Professional publication - NPS News | Health Professionals | 2010-04-01 00:00:00 |
| COPD - management and preventing progression | Covers identification and diagnosis of patients at risk of COPD - focuses on smokers and smoking cessation interventions. Treatment plans for acute exacerbations |
Professional publication - NPS News | Health Professionals | 2006-04-01 00:00:00 |
| Drug and alcohol management | Reviews drug and non-drug interventions for alcohol problems and smoking cessation. Case study on problem drinking |
Professional publication - NPS News | Health Professionals | 2002-06-01 00:00:00 |
| Evaluation of prescription drugs in Australia | A synopsis of the evaluation, dosage management and regulation of drugs in Australia, along with issues surrounding approaches to new drugs |
Professional publication - NPS News | Health Professionals | 2001-12-01 00:00:00 |
| NPS News 5: Bronchodilator therapy and corticosteroids for chronic obstructive pulmonary disease | Diagnosing COPD; bronchodilators and corticosteroids in treatment; nicotine replacement therapy for smoking cessation, and a report on case study 2 (otitis media). Otitis media case study |
Professional publication - NPS News | Health Professionals | 1999-08-01 00:00:00 |
| NPS Prescribing Practice Review 33: COPD: interventions for better outcomes | Information on diagnosis and drug treatment plans for patients with stable COPD, along with advice on smoking cessation and an action plan for acute exacerbations. |
Professional publication - Prescribing Practice Review | Health Professionals | 2006-05-01 00:00:00 |
| NPS Prescribing Practice Review 33: COPD: interventions for better outcomes | Information on diagnosis and drug treatment plans for patients with stable COPD, along with advice on smoking cessation and an action plan for acute exacerbations. |
Professional publication - Prescribing Practice Review | Health Professionals | 2006-05-01 00:00:00 |
| NPS Prescribing Practice Review 20: Smoking cessation | Information on the stages of change in smoking cessation, non-drug therapy in those ready to quit, and the use of nicotine replacement therapy and bupropion. |
Professional publication - Prescribing Practice Review | Health Professionals | 2002-10-30 00:00:00 |
| Quitting smoking and managing stable COPD | Overview of advice from health professionals to help people give up smoking. Quitting smoking can sustain airways in those with COPD or asthma |
Professional publication - Prescribing Practice Review | Health Professionals | 2010-05-01 00:00:00 |
| Community Update 24 | This new Community Update includes information on new resources for Arabic speakers; education seminars for Chinese, Italian, Greek, Vietnamese and Arabic-speaking seniors; review of medicines for hip and knee replacements; quitting smoking; women warned aspirin reports may be misleading; Health Minutes videos and radio interviews with Dr John D’Arcy |
Consumer publication - Community Update | Consumers | 2010-04-29 00:00:00 |
| New program to identify at-risk smokers and help them quit | A quit smoking education program by NPS helps doctors and pharmacists develop smoking cessation programs especially for patients with chronic obstructive pulmonary disease (COPD). |
Media release | Others | 2010-04-08 19:00:00 |
| Quitting is worth it | Quitting smoking has immediate long-term health benefits. Find out ways to help you quit smoking. |
Consumer publication - MedicinesTalk | Consumers | 2009-08-13 00:00:00 |
| MedicinesTalk No. 30 Winter 2009 | MedicinesTalk Winter 2009 has articles on getting a good night's sleep, losing weight, quitting smoking and the new peer education session: More than medicines-living well. |
Consumer publication - MedicinesTalk | Consumers | 2009-08-17 00:00:00 |
| Varenicline (Champix) for quitting smoking | Find out what varenicline does, its side effects, and how it compares with other medicines for quitting. Find out about ways to quit without medicines too. |
Consumer publication - Medicine Update | Consumers | 2011-08-02 00:00:00 |
| Lifestyle and medicine choices for better health | A consumer fact sheet on making changes to your lifestyle and the way you use your medicines may improve your health. |
Consumer publication - NPS factsheet | Consumers | 2009-04-21 00:00:00 |
| Side effects warning about varenicline (Champix) | The National Prescribing Service Limited (NPS) advises people taking the quit-smoking drug varenicline (marketed in Australia as Champix) to speak to their GP or pharmacist or contact Medicines Line if they are concerned about possible side effects. |
Media release | Others | 2008-12-04 00:00:00 |
| Will power and support are key to quitting | National Prescribing Service Limited (NPS) advises people wishing to take the new drug varenicline (Champix) to help them quit smoking, to be aware of the possible side effects and to discuss any concerns they have with their doctor or pharmacist |
Media release | Others | 2008-01-04 00:00:00 |
| Monitor and support patients on varenicline | Monitor and support patients on varenicline |
Media release | Others | 2008-01-07 00:00:00 |
| Quit smoking medicine: new study notes more side effects | National Prescribing Service (NPS) advises people with questions about the quit-smoking drug varenicline (Champix) to contact their doctor or pharmacist for advice due to concerns about potential adverse events. |
Media release | Others | 2008-05-22 00:00:00 |
| Keep an eye on quit-smoking patients using varenicline | NPS urges health professionals to monitor patients using varenicline (used by quit smoking patients) for any behaviour and/or mood changes or any unusual symptoms or events that occur while taking the medicine. |
Media release | Others | 2008-05-22 00:00:00 |
| New information on Varenicline (Champix) inconclusive: NPS (health professionals) | Uncertainty remains despite new research published this month linking a smoking-cessation medicine to an increased risk of heart attacks, according to NPS |
Media release | Others | 2011-07-20 19:00:00 |
| New information on Varenicline (Champix) inconclusive: NPS (for consumers) | New research linking an anti-smoking medicine to an increased risk of heart attacks remains uncertain. Anyone with concerns about taking the medicine should talk to their health professional or seek more information, according to NPS MedicineWise |
Media release | Others | 2011-07-20 19:00:00 |
| Which side effects matter? A smoker’s story | Read how a smoker decided which side effects were important to them. |
Consumer resource - Story | Consumers | 2011-01-24 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
